Diamyd Medical appoints Niklas Axelsson as CFO

Niklas Axelsson has been appointed CFO of Diamyd Medical. He will assume his position in August and will also join the management team. Niklas Axelsson brings more than 25 years of experience across the pharmaceutical, biotech, and financial sectors.“With Phase 3 readout expected in less than a year, Diamyd Medical is entering a critical stage in its development”, says Ulf Hannelius, CEO of Diamyd Medical. Niklas Axelsson’s proven financial leadership in both global pharma and emerging biotech makes him an ideal addition to our executive team.” "This is a particularly exciting moment to